Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-12 Sale |
2021-02-17 8:39 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner |
2,216,798 | $65 | $144,091,870 | 10,084,938 (Indirect) |
View |
| 2020-12-11 Sale |
2020-12-15 4:47 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner |
64,624 | $80.14 | $5,179,285 | 12,585,045 (Indirect) |
View |
| 2020-08-12 Sale |
2020-08-14 4:50 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner |
1,443,247 | $31.65 | $45,678,768 | 12,649,669 (Indirect) |
View |
| 2020-06-26 Sale |
2020-06-30 7:17 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner |
250,000 | $23.97 | $5,993,052 | 14,092,916 (Indirect) |
View |
| 2020-06-19 Sale |
2020-06-23 5:41 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner |
255,000 | $24.72 | $6,304,373 | 14,342,916 (Indirect) |
View |
| 2020-06-05 Sale |
2020-06-09 4:10 pm |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner |
1,922,855 | $25.75 | $49,513,516 | 14,597,916 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-02 Gift |
2024-12-04 4:47 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K 10% Owner |
40,000 | $0 | 10,026,111 (Indirect) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:07 pm |
N/A N/A |
MIDWEST HOLDING INC. | MDWT | BRATTON DOUGLAS K CRESTLINE ASSURANCE HOLDINGS LLC Crestline Management LP Crestline Investors Inc. Director 10% Owner |
2,674 | $0 | 447,845 (Indirect) |
View |
| 2021-11-11 Option Award |
2021-11-15 4:18 pm |
N/A N/A |
MIDWEST HOLDING INC. | MDWT | BRATTON DOUGLAS K CRESTLINE ASSURANCE HOLDINGS LLC Crestline Management LP Crestline Investors Inc. Director 10% Owner |
727 | $0 | 445,171 (Indirect) |
View |
| 2021-03-12 Other |
2021-03-16 8:20 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K MonoLine Partners L.P. MonoLine RX L.P. MonoLine RX II L.P. MonoLine RX III L.P. MonoSol Rx Genpar L.P. MRX Partners LLC Bratton Capital Inc. Bratton Capital Management L.P. 10% Owner |
5,259,492 | $0 | 7,220,655 (Indirect) |
View |
| 2021-03-09 Gift |
2021-03-16 8:20 pm |
N/A N/A |
Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K MonoLine Partners L.P. MonoLine RX L.P. MonoLine RX II L.P. MonoLine RX III L.P. MonoSol Rx Genpar L.P. MRX Partners LLC Bratton Capital Inc. Bratton Capital Management L.P. 10% Owner |
62,500 | $0 | 7,220,655 (Direct) |
View |
| 2020-12-21 Other |
2020-12-23 6:44 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner |
383,411 | $0 | 12,585,045 (Indirect) |
View |
| 2020-07-31 Option Award |
2020-08-04 9:15 pm |
N/A 2020-07-31 |
MIDWEST HOLDING INC. | MDWT | BRATTON DOUGLAS K CRESTLINE ASSURANCE HOLDINGS LLC Crestline Management LP Crestline Investors Inc. Director 10% Owner |
50,000 | $0 | 50,000 (Indirect) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:05 pm |
2021-06-16 2030-06-16 |
Aquestive Therapeutics Inc. | AQST | BRATTON DOUGLAS K Director 10% Owner |
14,000 | $0 | 11,592,379 (Direct) |
View |
Ownership |
2020-05-04 1:55 pm |
N/A N/A |
MIDWEST HOLDING INC. | MDWT | BRATTON DOUGLAS K CRESTLINE ASSURANCE HOLDINGS LLC Crestline Management LP Crestline Investors Inc. Director 10% Owner |
0 | $0 | 222,222,222 (Indirect) |
View |